Lithium Ion

Lithium Ion

SCHEMBL22470190

O=C([O-])C1CCN(CCc2ccc(Br)cc2)CC1.[Li+]

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.52
HTR2C P28335 2/20 0.52
HTR7 P34969 2/20 0.52
HTR6 P50406 2/20 0.52
THRB P10828 1/20 0.46
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.45
HIF1A Q16665 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ALDH1A1 P00352 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
KCNH2 Q12809 1/20 0.43
GRM2 Q14416 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15566801 0.85 HTR2A (0.57) HTR2AHTR2CHTR7HTR6THRB
Lithium Ion SCHEMBL22470294 0.85 HTR2A (0.69) HTR2A
Lithium Ion SCHEMBL22470304 0.84 HTR2A (0.50) HTR2AHTR2CHTR7HTR6KCNH2
SCHEMBL22470212 0.83 HTR2A (0.52) HTR2AHTR2CHTR7HTR6THRB
SCHEMBL22470373 0.81 ALDH1A1 (0.64) HTR2AHTR2CHTR7HTR6THRB
Fumaric Acid SCHEMBL15567315 0.80 HTR2A (0.51) HTR2AHTR2CHTR7HTR6THRB
SCHEMBL22483721 0.79 ALDH1A1 (0.52) HTR2AHTR2CHTR7HTR6THRB
SCHEMBL24495209 0.79 SPHK1 (0.63) HTR2AHTR2CHTR7HTR6THRB
Lithium Ion SCHEMBL22470296 0.77 ALDH1A1 (0.63) HTR2AKDM4ELMNAL3MBTL1ALDH1A1
SCHEMBL22233246 0.76 SIGMAR1 (0.61) HTR2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2022-05-19 US disclosed
EP-3941900-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 Deutsches Krebsforschungszentrum (DE) 2022-01-26 EP disclosed
WO-2020193431-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2020-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 HDAC10, HDAC1, HDAC11 HTR2A 4528/4885HTR2C 4743/4885HTR7 4184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.